Clinical Safety and Efficacy of Kanglaite®(Coix Seed Oil) Injection Combined with Chemotherapy in Treating Patients with Gastric Cancer

Authors:
  • XHXin-En Huang
    Xin-En Huang
  • JCJie Cao
    Jie Cao
  • YLYan-Yan Lu
    Yan-Yan Lu
  • XWXue-Yan Wu
    Xue-Yan Wu
  • JLJin Liu
    Jin Liu
  • XXXia Xu
    Xia Xu
  • JXJin Xiang
    Jin Xiang
  • LYLi-Hong Ye
    Li-Hong Ye

Abstract
To observe efficacy and side effects, as well as the impact on quality of life, of Kanglaite® (Coix Seed Oil) injections combined with chemotherapy in the treatment of advanced gastric cancer patiensts. A consecutive cohort of 60 patients were divided into two groups:the experimental group receiving Kanglaite® Injection combined with chemotherapy and the control group with chemotherapy alone. After more than two courses of treatment, efficacy, quality of life and side effects were evaluated. The response rate and KPS score of experimental group were significantly improved as compared with those of the control group(P<0.05). In addition, gastrointestinal reactions and bone marrow suppression were significantly lower than in the control group(P<0.05). Kanglaite® Injection enhanced efficacy and reduced the side effects of chemotherapy, improving quality of life of gastric cancer patients; use of Kanglaite® injections deserves to be further investigated in randomized control clinical trails.

This publication has 9 references indexed in Scilit: